May 12, 2022
Shionogi’s FY2021 revenue saw a two-digit gain year on year thanks to the strong performance of its novel siderophore cephalosporin antibiotic injection cefiderocol in the US and Europe and an increase in royalties related to the HIV franchise, which together...read more